SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-272430
Filing Date
2023-11-07
Accepted
2023-11-07 16:10:56
Documents
3
Period of Report
2023-11-07
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d576843d8k.htm 8-K 17364
2 EX-3.1 d576843dex31.htm EX-3.1 27755
3 EX-3.2 d576843dex32.htm EX-3.2 111551
  Complete submission text file 0001193125-23-272430.txt   157823
Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Filer) CIK: 0001907108 (see all company filings)

IRS No.: 854012572 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41855 | Film No.: 231383819
SIC: 2836 Biological Products, (No Diagnostic Substances)